Back to trial details

Intake questionnaire

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Applying to Sarah Cannon Research Center · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Cancer?
3. Are you able to travel to Nashville for study visits?